Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-22

Clinical Trial Update: Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the pharmacodynamics and efficacy of Leuprolide tablets (Ovarest) in women with endometriosis is ongoing, with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ovarest (Leuprolide)

Snippet

Sponsor: Enteris BioPharma Inc. | Conditions: Endometriosis | Phase 2 | Status: UNKNOWN